Aptose Biosciences Inc
TSX:APS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
Palatin Technologies Inc
F:PTN
|
US |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
Crescent Biopharma Inc
F:C68
|
US |
|
B
|
Bank of America Corp
SIX:BAC
|
US |
|
P
|
Patterson Companies Inc
F:PD2
|
US |
|
A
|
American Express Co
XBER:AEC1
|
US |
|
Nurexone Biologic Inc
F:J90
|
CA |
|
AES Corp
NYSE:AES
|
US |
|
Sunoco LP
NYSE:SUN
|
US |
|
Atmos Energy Corp
NYSE:ATO
|
US |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
Bank of the Philippine Islands
OTC:BPHLY
|
PH |
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
U
|
United Insurance Holdings Corp
F:0UI
|
US |
|
D
|
Dr Martens PLC
OTC:DOCMF
|
UK |
|
B
|
Bombardier Inc
OTC:BDRBF
|
CA |
|
W
|
Walt Disney Co
XMUN:WDP
|
US |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
A
|
American Express Co
F:AEC1
|
US |
|
Polyplex Corp Ltd
NSE:POLYPLEX
|
IN |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
A
|
Altea Green Power SpA
MIL:AGP
|
IT |
Bankruptcy Probability
Aptose Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptose Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
5.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptose Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptose Biosciences Inc has total debt of 10m USD. This includes both short-term (0 USD) and long-term (10m USD) debt.
You can find a full breakdown on its Balance Sheet.
